{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T03:52:16Z","timestamp":1768535536244,"version":"3.49.0"},"reference-count":14,"publisher":"International Heart Journal (Japanese Heart Journal)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int. Heart J."],"published-print":{"date-parts":[[2021,3,30]]},"DOI":"10.1536\/ihj.20-624","type":"journal-article","created":{"date-parts":[[2021,3,16]],"date-time":"2021-03-16T22:11:03Z","timestamp":1615932663000},"page":"441-444","source":"Crossref","is-referenced-by-count":2,"title":["Therapeutic Strategy for a Patient with Advanced Heart Failure and Schizophrenia Without Cardiac Replacement Therapies"],"prefix":"10.1536","volume":"62","author":[{"given":"Masakazu","family":"Hori","sequence":"first","affiliation":[{"name":"Second Department of Internal Medicine, University of Toyama"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teruhiko","family":"Imamura","sequence":"additional","affiliation":[{"name":"Second Department of Internal Medicine, University of Toyama"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Makiko","family":"Nakamura","sequence":"additional","affiliation":[{"name":"Second Department of Internal Medicine, University of Toyama"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaki","family":"Nakagaito","sequence":"additional","affiliation":[{"name":"Second Department of Internal Medicine, University of Toyama"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koichiro","family":"Kinugawa","sequence":"additional","affiliation":[{"name":"Second Department of Internal Medicine, University of Toyama"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"437","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Kormos RL, Cowger J, Pagani FD, <i>et al<\/i>. The Society of Thoracic Surgeons Intermacs database annual report: evolving indications, outcomes, and scientific partnerships. J Heart Lung Transplant 2019; 38: 114-26.","DOI":"10.1016\/j.healun.2018.11.013"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. McIlvennan CK, Allen LA, Nowels C, Brieke A, Cleveland JC, Matlock DD. Decision making for destination therapy left ventricular assist devices: &quot;there was no choice&quot; versus &quot;I thought about it an awful lot&quot; . Circ Cardiovasc Qual Outcomes 2014; 7: 374-80.","DOI":"10.1161\/CIRCOUTCOMES.113.000729"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Kavalieratos D, Gelfman LP, Tycon LE, <i>et al<\/i>. Palliative care in heart failure: rationale, evidence, and future priorities. J Am Coll Cardiol 2017; 70: 1919-30.","DOI":"10.1016\/j.jacc.2017.08.036"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Houben CH, Spruit MA, Wouters EF, Janssen DJ. A randomised controlled trial on the efficacy of advance care planning on the quality of end-of-life care and communication in patients with COPD: the research protocol. BMJ Open  2014; 4: e004465.","DOI":"10.1136\/bmjopen-2013-004465"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Lund LH, Edwards LB, Dipchand AI, <i>et al<\/i>. The Registry of the International Society for Heart and Lung Transplantation: Thirty-third adult heart transplantation Report-2016; focus theme: primary diagnostic indications for transplant. J Heart Lung Transplant 2016; 35: 1158-69.","DOI":"10.1016\/j.healun.2016.08.017"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Kinugawa K, Nishimura T, Toda K, <i>et al<\/i>. The second official report from Japanese registry for mechanical assisted circulatory support (J-MACS): first results of bridge to bridge strategy. Gen Thorac Cardiovasc Surg 2020; 68: 102-11.","DOI":"10.1007\/s11748-019-01227-y"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Kurozumi Y, Oishi S, Sugano Y, <i>et al<\/i>. Possible associations between palliative care conferences and positive outcomes when performing palliative care for patients with end-stage heart failure: a nationwide cross-sectional questionnaire survey. Heart Vessels 2019; 34: 452-61.","DOI":"10.1007\/s00380-018-1261-y"},{"key":"8","doi-asserted-by":"publisher","unstructured":"8. Writing Committee M, Yancy CW, Jessup M, <i>et al<\/i>. 2013 ACCF\/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines. Circulation 2013; 128: e240-327.","DOI":"10.1161\/CIR.0b013e31829e8776"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Dew MA, DiMartini AF, Dobbels F, <i>et al<\/i>. The 2018 ISHLT\/APM\/AST\/ICCAC\/STSW recommendations for the psychosocial evaluation of adult cardiothoracic transplant candidates and candidates for long-term mechanical circulatory support. J Heart Lung Transplant 2018; 37: 803-23, 2013.","DOI":"10.1016\/j.psym.2018.04.003"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. O&apos;Connor CM, Jiang W, Kuchibhatla M, <i>et al<\/i>. Safety and efficacy of sertraline for depression in patients with heart failure: results of the SADHART-CHF (sertraline against Depression and Heart Disease in Chronic Heart Failure) trial. J Am Coll Cardiol 2010; 56: 692-9.","DOI":"10.1016\/j.jacc.2010.03.068"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Angermann CE, Gelbrich G, St\u00f6rk S, <i>et al<\/i>. Effect of escitalopram on all-cause mortality and hospitalization in patients with heart failure and depression: the MOOD-HF randomized clinical trial. JAMA 2016; 315: 2683-93.","DOI":"10.1001\/jama.2016.7635"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Parshall MB, Schwartzstein RM, Adams L, <i>et al<\/i>. An official American Thoracic Society statement: update on the mechanisms, assessment, and management of dyspnea. Am J Respir Crit Care Med 2012; 185: 435-52.","DOI":"10.1164\/rccm.201111-2042ST"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Vismara LA, Leaman DM, Zelis R. The effects of morphine on venous tone in patients with acute pulmonary edema. Circulation 1976; 54: 335-7.","DOI":"10.1161\/01.CIR.54.2.335"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Johnson MJ, McDonagh TA, Harkness A, McKay SE, Dargie HJ. Morphine for the relief of breathlessness in patients with chronic heart failure--a pilot study. Eur J Heart Fail 2002; 4: 753-6.","DOI":"10.1016\/S1388-9842(02)00158-7"}],"container-title":["International Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/ihj\/62\/2\/62_20-624\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,3]],"date-time":"2021-04-03T04:02:07Z","timestamp":1617422527000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/ihj\/62\/2\/62_20-624\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,30]]},"references-count":14,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1536\/ihj.20-624","relation":{},"ISSN":["1349-2365","1349-3299"],"issn-type":[{"value":"1349-2365","type":"print"},{"value":"1349-3299","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,30]]}}}